INVESTMENTS AND FAIR VALUE DISCLOSURES (Tables)
|
3 Months Ended |
Mar. 31, 2025 |
Fair Value Disclosures [Abstract] |
|
Schedule of Components of the Company's Investments |
The following table presents the components of the Company’s investments: | | | | | | | | | | | | (dollars in thousands) | March 31, 2025 | | December 31, 2024 | Preferred equity investment, at fair value | $ | 268,263 | | | $ | 267,169 | | Equity investments in the Company’s products, at fair value | 73,276 | | | 96,956 | | Equity investments in the Company’s products, equity method | 62,252 | | | 63,465 | | Loans and deferred purchase price receivable, at amortized cost (includes $48,586 and $48,094 of investments in the Company’s products, respectively) | 54,643 | | | 54,186 | | Investments in the Company’s CLOs, at fair value | 7,702 | | | 5,169 | | | | | | Total | $ | 466,136 | | | $ | 486,945 | |
|
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis |
The tables below summarizes the Company’s assets and liabilities measured at fair value on a recurring basis as of March 31, 2025 and December 31, 2024: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | March 31, 2025 | (dollars in thousands) | | Level I | | Level II | | Level III | | Total | Investments, at Fair Value | | | | | | | | | | | | | | | | | | | | | | | | | | | Preferred equity investment | | $ | — | | | $ | — | | | $ | 268,263 | | | $ | 268,263 | | Equity investments in the Company’s products | | — | | | 73,276 | | | — | | | 73,276 | | CLOs | | — | | | — | | | 7,702 | | | 7,702 | | Total Assets, at Fair Value | | $ | — | | | $ | 73,276 | | | $ | 275,965 | | | $ | 349,241 | | | | | | | | | | | Liabilities, at Fair Value | | | | | | | | | TRA liability | | $ | — | | | $ | — | | | $ | 97,228 | | | $ | 97,228 | | | | | | | | | | | Earnout liability | | — | | | 526 | | | 305,680 | | | 306,206 | | Total Liabilities, at Fair Value | | $ | — | | | $ | 526 | | | $ | 402,908 | | | $ | 403,434 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | December 31, 2024 | (dollars in thousands) | | Level I | | Level II | | Level III | | Total | Investments, at Fair Value | | | | | | | | | | | | | | | | | | | | | | | | | | | Preferred equity investment | | $ | — | | | $ | — | | | $ | 267,169 | | | $ | 267,169 | | Equity investments in the Company’s products | | — | | | 96,956 | | | — | | | 96,956 | | CLOs | | — | | | — | | | 5,169 | | | 5,169 | | Total Assets, at Fair Value | | $ | — | | | $ | 96,956 | | | $ | 272,338 | | | $ | 369,294 | | | | | | | | | | | Liabilities, at Fair Value | | | | | | | | | TRA liability | | $ | — | | | $ | — | | | $ | 108,257 | | | $ | 108,257 | | | | | | | | | | | Earnout liability | | — | | | 529 | | | 167,912 | | | 168,441 | | Total Liabilities, at Fair Value | | $ | — | | | $ | 529 | | | $ | 276,169 | | | $ | 276,698 | |
|
Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation |
The following table sets forth a summary of changes in the fair value of the Level III measurements for the three months ended March 31, 2025 and 2024: | | | | | | | | | | | | | | | | | | Three Months Ended March 31, 2025 | Level III Assets | (dollars in thousands) | Preferred Equity | | CLOs | | Total | Beginning balance | $ | 267,169 | | | $ | 5,169 | | | $ | 272,338 | | Purchases(1) | 8,081 | | | 3,986 | | | 12,067 | | Net losses | (6,987) | | | (1,453) | | | (8,440) | | Ending Balance | $ | 268,263 | | | $ | 7,702 | | | $ | 275,965 | | Change in net unrealized losses on assets still recognized at the reporting date | $ | (6,987) | | | $ | (1,453) | | | $ | (8,440) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(1)Preferred equity purchases includes $8.1 million of cumulative unpaid cash preferential dividends that compound quarterly and are payable when declared. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, 2024 | Level III Assets | (dollars in thousands) | CLOs | | Total | Beginning balance | $ | 2,521 | | | $ | 2,521 | | Net losses | (144) | | | (144) | | Ending Balance | $ | 2,377 | | | $ | 2,377 | | Change in net unrealized losses on assets still recognized at the reporting date | $ | (144) | | | $ | (144) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, 2025 | Level III Liabilities | (dollars in thousands) | TRA Liability | | | | Earnout Liability | | Total | Beginning balance | $ | 108,257 | | | | | $ | 167,912 | | | $ | 276,169 | | Issuances | — | | | | | 140,083 | | | 140,083 | | | | | | | | | | Settlements | (14,556) | | | | | — | | | (14,556) | | Net (gains) losses | 3,527 | | | | | (2,315) | | | 1,212 | | Ending Balance | $ | 97,228 | | | | | $ | 305,680 | | | $ | 402,908 | | Change in net unrealized (gains) losses on liabilities still recognized at the reporting date | $ | 3,527 | | | | | $ | (2,315) | | | $ | 1,212 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, 2024 | Level III Liabilities | (dollars in thousands) | TRA Liability | | Warrant Liability | | Earnout Liability | | Total | Beginning balance | $ | 116,398 | | | $ | 22,600 | | | $ | 92,119 | | | $ | 231,117 | | Settlements | (8,551) | | | — | | | (82,875) | | | (91,426) | | Net (gains) losses | (536) | | | 14,700 | | | 402 | | | 14,566 | | Ending Balance | $ | 107,311 | | | $ | 37,300 | | | $ | 9,646 | | | $ | 154,257 | | Change in net unrealized (gains) losses on liabilities still recognized at the reporting date | $ | (536) | | | $ | 14,700 | | | $ | 402 | | | $ | 14,566 | |
|
Schedule of Fair Value Measurement Inputs and Valuation Techniques |
The following table summarizes the quantitative inputs and assumptions used for the Company’s Level III measurements as of March 31, 2025: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (dollars in thousands) | | Fair Value | | Valuation Technique | | Significant Unobservable Inputs | | Range | | Weighted Average | | Impact to Valuation from an Increase in Input | Assets | | | | | | | | | | | | | | | Preferred equity | | $ | 268,263 | | | Discounted cash flow | | Discount Rate | | 13 | % | - | 13% | | 13 | % | | Decrease | CLOs | | 7,702 | | | Discounted cash flow | | Yield | | 10 | % | - | 15% | | 11 | % | | Decrease | Total Assets, at Fair Value | | $ | 275,965 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Liabilities | | | | | | | | | | | | | | | TRA liability | | $ | 97,228 | | | Discounted cash flow | | Discount Rate | | 13 | % | - | 13% | | 13 | % | | Decrease | | | | | | | | | | | | | | | | Earnout liability: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 180,364 | | | Monte Carlo Simulation | | Volatility | | 21 | % | - | 37% | | 24 | % | | Increase | | | 125,316 | | | Discounted cash flow | | Discount Rate | | 0 | % | - | 6% | | 0 | % | | Decrease | | | 305,680 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total Liabilities, at Fair Value | | $ | 402,908 | | | | | | | | | | | | | |
The following table summarizes the quantitative inputs and assumptions used for the Company’s Level III measurements as of December 31, 2024: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (dollars in thousands) | | Fair Value | | Valuation Technique | | Significant Unobservable Inputs | | Range | | Weighted Average | | Impact to Valuation from an Increase in Input | Assets | | | | | | | | | | | | | | | Preferred equity | | $ | 267,169 | | | Discounted cash flow | | Discount Rate | | 13 | % | - | 13% | | 13 | % | | Decrease | CLOs | | 5,169 | | | Discounted cash flow | | Yield | | 10 | % | - | 16% | | 12 | % | | Decrease | Total Assets, at Fair Value | | $ | 272,338 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Liabilities | | | | | | | | | | | | | | | TRA liability | | $ | 108,257 | | | Discounted cash flow | | Discount Rate | | 13 | % | - | 13% | | 13 | % | | Decrease | | | | | | | | | | | | | | | | Earnout liability: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 163,001 | | | Monte Carlo Simulation | | Volatility | | 20 | % | - | 37% | | 29 | % | | Increase | | | 4,911 | | | Discounted cash flow | | Discount Rate | | 6 | % | - | 6% | | 6 | % | | Decrease | | | 167,912 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total Liabilities, at Fair Value | | $ | 276,169 | | | | | | | | | | | | | |
|